FDA accepts BioMimetics PMA application for its human platelet-derived growth factor (rhPDGF-BB) for use in foot and ankle fusions

By

BioMimetic Therapeutics Receives Filing Letter from FDA for Augment™ Bone Graft PMA (Press Release)...

Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top